Vitamin D and the promoter methylation of its metabolic pathway genes in association with the risk and prognosis of tuberculosis
2018 · Clinical Epigenetics · 61 citations
https://doi.org/10.1186/s13148-018-0552-6
W
Weimin Kong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
116
Papers
1.5K
Citations
22
h-index
38
i10-index
Weimin Kong is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Cervical Cancer and HPV Research & Cancer, Lipids, and Metabolism. The author has an h-index of 22, co-authored 99 publications.
ORCID: 0000-0002-4429-3242Papers by this author
worksThe role of DGAT1 and DGAT2 in regulating tumor cell growth and their potential clinical implications
2024 · Journal of Translational Medicine · 38 citations
https://doi.org/10.1186/s12967-024-05084-z
circFAM120B functions as a tumor suppressor in esophageal squamous cell carcinoma via the miR-661/PPM1L axis and the PKR/p38 MAPK/EMT pathway
2022 · Cell Death and Disease · 28 citations
https://doi.org/10.1038/s41419-022-04818-5
Practice guideline on ovarian tissue cryopreservation and transplantation in the prevention and treatment of iatrogenic premature ovarian insufficiency
2024 · Maturitas · 22 citations
https://doi.org/10.1016/j.maturitas.2024.107922
Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma
2023 · BMC Medical Genomics · 8 citations
https://doi.org/10.1186/s12920-023-01463-5
Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer
2024 · Gynecologic Oncology · 5 citations
https://doi.org/10.1016/j.ygyno.2024.04.012
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat